Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S SHULMAN

Showing results (181-190 of 234) with videos related to

Pageof 24
Sort By:
European Journal of Gastroenterology & Hepatology|May 16, 2018
Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV)Vasily Isakov, Dzmitry Paduta, Rolando M Viani, et al.
The Journal of Infectious Diseases|March 23, 2017
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on DarunavirDavid Wyles, Michael Saag, Rolando M Viani, et al.
Pediatric Blood & Cancer|September 16, 2023
Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcomaKevin Campbell, Andrew Posner, Nan Chen, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Characterization of hepatitis C virus (HCV) quasispecies dynamics upon short-term dual therapy with the HCV NS5B nucleoside polymerase inhibitor mericitabine and the NS3/4 protease inhibitor danoprevirS Le Pogam, J M Yan, M Chhabra, et al.
Journal of Hepatology|March 1, 2011
Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patientsEdward J Gane, Regine Rouzier, Catherine Stedman, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Multi-omic Longitudinal Analysis of Canine Osteosarcoma Identifies Inter-Patient Heterogeneity and Immune Enrichment in Metastatic LesionsChristopher Husted, Kerstin Seidel, Tanya T Karagiannis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2022
Rapid and highly sensitive approach for multiplexed somatic fusion detectionSamuel Abbou, Sarah Finstuen-Magro, Brigit McDannell, et al.
Radiology|March 1, 1987
Mediastinal lymph node metastases from bronchogenic carcinoma: detection with MR imaging and CTP Y Poon, M J Bronskill, R M Henkelman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2000
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic responseN S Shulman, A R Zolopa, D J Passaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2005
Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infectionThomas B Campbell, Nancy S Shulman, Steven C Johnson, et al.
Pageof 24

Showing results (181-190 of 234) with videos related to

Sort By:
Pageof 24
European Journal of Gastroenterology & Hepatology|May 16, 2018
Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV)Vasily Isakov, Dzmitry Paduta, Rolando M Viani, et al.
The Journal of Infectious Diseases|March 23, 2017
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on DarunavirDavid Wyles, Michael Saag, Rolando M Viani, et al.
Pediatric Blood & Cancer|September 16, 2023
Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcomaKevin Campbell, Andrew Posner, Nan Chen, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Characterization of hepatitis C virus (HCV) quasispecies dynamics upon short-term dual therapy with the HCV NS5B nucleoside polymerase inhibitor mericitabine and the NS3/4 protease inhibitor danoprevirS Le Pogam, J M Yan, M Chhabra, et al.
Journal of Hepatology|March 1, 2011
Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patientsEdward J Gane, Regine Rouzier, Catherine Stedman, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Multi-omic Longitudinal Analysis of Canine Osteosarcoma Identifies Inter-Patient Heterogeneity and Immune Enrichment in Metastatic LesionsChristopher Husted, Kerstin Seidel, Tanya T Karagiannis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2022
Rapid and highly sensitive approach for multiplexed somatic fusion detectionSamuel Abbou, Sarah Finstuen-Magro, Brigit McDannell, et al.
Radiology|March 1, 1987
Mediastinal lymph node metastases from bronchogenic carcinoma: detection with MR imaging and CTP Y Poon, M J Bronskill, R M Henkelman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2000
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic responseN S Shulman, A R Zolopa, D J Passaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2005
Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infectionThomas B Campbell, Nancy S Shulman, Steven C Johnson, et al.
Pageof 24